Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

5.49

-0.15 (-2.66%)

At close: May 15, 2025, 4:00 PM

6.05

+0.56 (10.25%)

After-hours: May 15, 2025, 7:59 PM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $297.99 million as of May 15, 2025. Its market cap has increased by 201.91% in one year.

Market Cap

297.99M

Enterprise Value

821.59M

1-Year Change

201.91%

Ranking

#3329

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has decreased from $320.80M to $297.99M, a decrease of -7.11%. That is a compound annual growth rate of -0.40%.

Market Cap History

Date	Market Cap	% Change
May 14, 2025	306.10M	-40.91%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.76B
Johnson & Johnson	357.16B
AbbVie	332.08B
Novo Nordisk	291.59B
UnitedHealth Group	282.47B
Abbott Laboratories	224.53B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings